Regular Article
Use of alternative therapies in menopause

https://doi.org/10.1053/beog.2002.0290Get rights and content

Abstract

Hormone replacement therapy has traditionally been used to treat the accompanying symptoms of oestrogen deficiency in menopause. However, not all women can, or prefer to, receive this treatment and alternatives should be considered to reduce the increased risk of osteoporosis and heart disease in menopausal women. This chapter reviews the current literature on the efficacy of phyto-oestrogens in preventing cardiovascular disease, various cancers and osteoporosis, as well as treating the vasomotor and other menopause-related symptoms. Select herbal therapies, as well as selective oestrogen receptor modulators, are also considered.

References (185)

  • DC Knight et al.

    A review of the clinical effects of phyto-oestrogens

    Obstetrics and Gynecology

    (1996)
  • JW Lampe et al.

    Urinary lignan and isoflavanoid excretion in premenopausal women consuming flaxseed powder

    American Journal of Clinical Nutrition

    (1994)
  • K DR Setchell et al.

    Mammalian lignans and phyto-oestrogens. Recent studies on their formation, metabolism and biological role in health and disease

  • H Adlercreutz et al.

    Inhibition of human aromatase by mammalian lignans and isoflavonoid phyto-oestrogens

    Journal of Steroid Biochemistry and Molecular Biology

    (1993)
  • A Keys et al.

    The seven countries study: 2,289 deaths in 15 years

    Preventive Medicine

    (1984)
  • KK Carroll

    Review of clinical studies on cholesterol-lowering response to soy protein

    Journal of American Dietary Association

    (1991)
  • A Cassidy et al.

    Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women

    American Journal of Clinical Nutrition

    (1994)
  • AL Murkies et al.

    Dietary flour supplementation decreases post-menopausal hot flushes: effect of soy and wheat

    Maturitas

    (1995)
  • RM Bakhit et al.

    Intake of 25 g of soybean protein with or without soybean fibre alters plasma lipids in men with elevated cholesterol concentrations

    Journal of Nutrition

    (1994)
  • CR Sirtori et al.

    Soybean-protein diet in the treatment of type-II hyperlipoproteinaemia

    Lancet

    (1977)
  • CR Sirtori et al.

    Soy and cholesterol reduction: clinical experience

    Journal of Nutrition

    (1995)
  • EW Raines et al.

    Biology of atherosclerotic plaque formation: possible role of growth factors in lesion development and the potential impact of soy

    Journal of Nutrition

    (1995)
  • T Fotsis et al.

    Genistein, a dietary ingested isoflavanoid, inhibits cell proliferation and in vitro angiogenesis

    Journal of Nutrition

    (1995)
  • MS Anthony et al.

    Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys

    Journal of Nutrition

    (1996)
  • KA Greaves et al.

    Intact dietary soy protein, but not adding an isoflavone-rich soy extract to casein, improves plasma lipids in ovariectomized cynomolgus monkeys

    Journal of Nutrition

    (1999)
  • MS Anthony et al.

    Effects of soy isoflavones on athesosrosis: potential mechanisms

    American Journal of Clinical Nutrition

    (1998)
  • JD Wagner et al.

    Dietary soy protein and oestrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgus monkeys

    Metabolism

    (1997)
  • JN Wilcox et al.

    Thrombotic mechanisms in atherosclerosis: potential impact of soy proteins

    Journal of Nutrition

    (1995)
  • HP Lee et al.

    Dietary effects on breast cancer risk in Singapore

    Lancet

    (1991)
  • H Adlercreutz et al.

    Dietary phyto-oestrogens and cancer: in vitro and in vivo studies

    Journal of Steroid Biochemistry and Molecular Biology

    (1992)
  • Y Mousavi et al.

    Genistein is an effective stimulator of SHBG production in Hep-G2 human liver cancer cells and suppresses proliferation of these cells in culture

    Steroids

    (1993)
  • H Adlercreutz et al.

    Excretion of lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian women and in women with breast cancer

    Lancet

    (1982)
  • H Adlercreutz et al.

    Urinary excretion of lignans and isoflavonoid phyto-oestrogens in Japanese men and women consuming traditional Japanese diet

    American Journal of Clinical Nutrition

    (1991)
  • D Ingram et al.

    Case-control study of phyto-oestrogens and breast cancer

    Lancet

    (1997)
  • AI Constantinou et al.

    Genistein induces maturation of cultured human breast cancer cells and prevents tumor growth in nude mice

    American Journal of Clinical Nutrition

    (1998)
  • M Gambacciani et al.

    Ipriflavone prevents the bone mass reduction in premenopausal women treated with gonadotropin hormone-releasing hormone agonists

    Bone and Mineral

    (1994)
  • SR Loewe et al.

    Uber weiliche sexual hormone (Thelytropine)

    Biochem Zeitschr

    (1927)
  • KR Price et al.

    Naturally occurring oestrogens in foods – a review

    Food Additives and Contamination

    (1985)
  • C Bannwart et al.

    Isoflavonic phyto-oestrogens in humans, identification and metabolism

    European Journal of Cancer and Clinical Oncology

    (1987)
  • L Markiewiez et al.

    In vitro bioassays of non-steroidal phyto-oestrogens

    Journal of Steroid Biochemistry and Molecular Biology

    (1993)
  • PM Martin et al.

    Phyto-oestrogen interaction with oestrogen receptors in human breast cancer cells

    Endocrinology

    (1978)
  • JF Couse et al.

    Tissue distribution and quantitative analysis of oestrogen receptor-alpha (ERalpha) and oestrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse

    Endocrinology

    (1997)
  • D Tham et al.

    Potential health benefits of dietary phyto-oestrogens: a review of the clinical, epidemiological, and mechanistic evidence

    Journal of Clinical Endocrinology and Metabolism

    (1998)
  • H Adlercreutz et al.

    Phyto-oestrogens and Western diseases

    Annals of Medicine

    (1997)
  • H Wang et al.

    Isoflavone composition of American and Japanese soybeans in Iowa: effects of variety, crop year, and location

    Journal of Agriculture and Food Chemistry

    (1994)
  • T Fotsis et al.

    Genistein, a dietary derived inhibitor of in-vitro angiogenesis

    Proceedings of the National Academy of Sciences of the USA

    (1993)
  • A Constantinou et al.

    Genistein as an inducer of tumor cell differentiation: possible mechanisms of action

    Proceedings of the Society for Experimental Biology and Medicine

    (1995)
  • H Wei et al.

    Inhibition of tumour promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein

    Nutrition and Cancer

    (1993)
  • H Wei et al.

    Antioxidant and antipromotional effects of the soybean isoflavone genistein

    Proceedings of the Society for Experimental Biology and Medicine

    (1995)
  • TG Petersen et al.

    Genistein inhibition of the growth of human breast cancer cells: independence from oestrogen receptors and the multi-drug resistance gene

    Biochemical and Biophysical Research Communications

    (1991)
  • Cited by (0)

    f1

    *Please send correspondence to: Michelle P. Warren MD, Columbia University, Department of Ob/Gyn, 622 W. 168th Street, PH 16–127, New York, NY 10032, USA

    View full text